GB2169312A - A method for producing proteins - Google Patents

A method for producing proteins Download PDF

Info

Publication number
GB2169312A
GB2169312A GB08500007A GB8500007A GB2169312A GB 2169312 A GB2169312 A GB 2169312A GB 08500007 A GB08500007 A GB 08500007A GB 8500007 A GB8500007 A GB 8500007A GB 2169312 A GB2169312 A GB 2169312A
Authority
GB
United Kingdom
Prior art keywords
living cells
cells
proteins
electromagnetic radiation
producing proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB08500007A
Other versions
GB8500007D0 (en
Inventor
Peter Beaconsfield
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BEACONSFIELD TINA
Original Assignee
BEACONSFIELD TINA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BEACONSFIELD TINA filed Critical BEACONSFIELD TINA
Priority to GB08500007A priority Critical patent/GB2169312A/en
Publication of GB8500007D0 publication Critical patent/GB8500007D0/en
Publication of GB2169312A publication Critical patent/GB2169312A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N13/00Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0023Agression treatment or altering
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76Albumins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

A method for producing proteins from living cells eg lymphocytes which method comprises irradiating the living cells with electromagnetic radiation of a frequency in the range of 10 x 10<6> Hz to 3 x 10<9> Hz.

Description

SPECIFICATION A Method for Producing Proteins The present invention relates to a method for producing proteins.
Proteins are complex polymers of amino-acids joined by peptide bonds. As presently performed the preparation of synthetic proteins from the constituent amino-acids is a complicated, expensive and inefficient procedure.
I have found that it is possible to induce living cells to produce increased amounts of proteins by irradiating them with electromagnetic radiation of specific energy levels.
Accordingly, the present invention provides a method of producing proteins from living cells which method comprises irradiating the living cells with electromagnetic radiation of a frequency in the range 10 x 106 Hzto 3 x 109 Hz.
Preferably the irradiation of the living cells is performed for periods of from 1 to 2 hours, followed by incubation of the cells for periods of for example, 2, 4, 6, 48, 72 or 120 hours.
Electromagnetic stimulation of the cells within the incubation medium was achieved using a signal generator, for example a Hewlett-Packard 5688A signal generator, through platinum needle or plate electrodes immersed in the incubation medium. For the higher ranges of frequency (i.e. above 300 MHz) coaxial cable was used.
The electromagnetic radiation may take the form of sine waves or square waves.
The following Examples illustrate the present invention.
Example 1 Globulin Production from Human Lymphocytes Standard, conventional procedures were used to isolate lymphocytes from whole blood taken from volunteers and used immediately. The isolated lymphocytes were suspended in an incubation medium RPMI 1640 (sold by Gibco) at a cell concentration of approximately 2 x 106 cells/ml. Glucose in a dose of 200 mg/100 ml was added to the incubation fluid. Where incubation was to last for more than 6 hours, 10% fetal calf serum was added to the fluid and an antibiotic incorporated to prevent infection in accordance with standard procedures for experiments involving relatively long periods of incubation. Samples (3, 4 or 5 ml) of incubation fluid carrying suspended lymphocytes were subjected to electromagnetic radiation at a frequency of 100 x 106 Hz at 25 A for 2 hours at 370C.The cells were irradiated in a chamber between opposed platinum plates, and the irradiation was performed using a Hewlett-Packard signal generator (Model Number 5686A) to generate sine waves at the chosen frequency. At the end of the period of irradiation, the samples were incubated for a further 6 or 12 hours. During incubation a flow of oxygen containing 5% CO2 was maintained.
Analysis of the samples for their content of y-globulins : IgG, IgM, and IgA was performed using standard measurement techniques such as those described in "Practical Immunology" by Hudson and Hay, Blackwells Scientific Publication, 1980. (See pages 233 - 239).
The following measurements were obtained: IgG lgM IgA (ng/100ml) (ng/100ml) (ng/100ml) Control Sample 1 1.9 < 1.0 < 1.0 Control Sample 2 1.6 < 1.0 < 1.0 Experiment Sample 1 10.1 1.8 2.8 Experiment Sample 2 8.3 2.1 1.9 Each sample has its own control, because human tissue is polymorphic.
The results demonstrate that the content of a-globulins is considerably increased in the irradiated samples relative to the control sample.
Radioactive studies demonstrated that the protein produced was newly synthesised, and not simply extruded by the cells into the medium. This new production was sustained for varying periods after stimulation had ceased.
Light and electron microscopy both gave evidence of increased cellular activity in the stimulated cells.
In all instances, stimulation of the same cell suspension can be repeated at intervals and further protein produced.
Example 2 Albumen Production from Liver Tissue Slices of liver tissue were taken either from otherwise healthy patients undergoing emergency abdomi nal surgery for repair of hepatic injury (usually resulting from a car accident) or from freshly killed Wistar rats. Each specimen weighed approximately 100 mg and was 1 mm thick. Two or three such specimens of liver tissue were suspended in 5 ml of the incubation medium described in Example 1, and then irradi ated in the same manner and with the same electromagnetic radiation as in Example 1. Experiments were started within 30 minutes of isolating the liver tissue.
The following measurements were obtained: Albumen in microgrammesilitre Control (1) 8.9 Stimulated (1) 10.9 Control (2) 8.7 Stimulated (2) 19.4 Control (3) 8.4 Stimulated (3) 15.4 Example 3 Insulin Production from Pancreas Tissue Example 2 was repeated, but using specimens of pancreas tissue instead of liver tissue. The specimens of pancreas tissue were taken from male mongrel dogs and were treated immediately in the usual manner to halt postmortem autolysis.
In each instance, newly synthesised insulin was recovered from the incubation medium.

Claims (13)

1. A method of producing proteins from living cells which method comprises irradiating the living cells with electromagnetic radiation of a frequency in the range 10 x 106 Hz to 3 x 109 Hz.
2. A method according to Claim 1, wherein the irradiation is performed for 1 to 2 hours.
3. A method according to Claim 1 or 2, wherein following irradiation the cells are incubated for a period of up to 120 hours.
4. A method according to any one of Claims 1 to 3, wherein the electromagnetic radiation is in the form of sine waves.
5. A method according to any one of Claims 1 to 3, wherein the electromagnetic radiation is in the form of square waves.
6. A method according to any one of the preceding claims, wherein the protein generated is globulin.
7. A method according to any one of Claims 1 to 5, wherein the protein generated is albumen.
8. A method according to any one of Claims 1 to 5, wherein the living cells are human lymphocytes.
9. A method according to any one of Claims 1 to 5, wherein the living cells are liver cells.
10. A method according to any one of Claims 1 to 5, wherein the living cells are pancreas cells.
11. A method according to Claim 10, wherein the said proteins are isolated and recovered from the living cells.
12. A method of producing proteins from living cells substantially as described in any one of the foregoing Examples.
13. Proteins whenever prepared by a method as ciaimed in any one of the preceding claims.
GB08500007A 1985-01-02 1985-01-02 A method for producing proteins Withdrawn GB2169312A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB08500007A GB2169312A (en) 1985-01-02 1985-01-02 A method for producing proteins

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB08500007A GB2169312A (en) 1985-01-02 1985-01-02 A method for producing proteins

Publications (2)

Publication Number Publication Date
GB8500007D0 GB8500007D0 (en) 1985-02-13
GB2169312A true GB2169312A (en) 1986-07-09

Family

ID=10572308

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08500007A Withdrawn GB2169312A (en) 1985-01-02 1985-01-02 A method for producing proteins

Country Status (1)

Country Link
GB (1) GB2169312A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2634381A1 (en) * 1988-07-25 1990-01-26 Morez Jean Bernard Method for the production of homeopathic medicaments in a single operation irrespective of the chosen dilution
WO1991010450A1 (en) * 1990-01-11 1991-07-25 Morez Jean Bernard Method for manufacturing homeopathic drugs in a single step and with any dilution
EP1991569A2 (en) * 2006-03-07 2008-11-19 Regenetech, Inc. Natively glycosylated mammalian biological molecules produced by eletromagnetically stimulating living mammalian cells

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4327180A (en) * 1979-09-14 1982-04-27 Board Of Governors, Wayne State Univ. Method and apparatus for electromagnetic radiation of biological material

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4327180A (en) * 1979-09-14 1982-04-27 Board Of Governors, Wayne State Univ. Method and apparatus for electromagnetic radiation of biological material

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2634381A1 (en) * 1988-07-25 1990-01-26 Morez Jean Bernard Method for the production of homeopathic medicaments in a single operation irrespective of the chosen dilution
WO1991010450A1 (en) * 1990-01-11 1991-07-25 Morez Jean Bernard Method for manufacturing homeopathic drugs in a single step and with any dilution
EP1991569A2 (en) * 2006-03-07 2008-11-19 Regenetech, Inc. Natively glycosylated mammalian biological molecules produced by eletromagnetically stimulating living mammalian cells
EP1991569A4 (en) * 2006-03-07 2009-12-23 Regenetech Inc Natively glycosylated mammalian biological molecules produced by eletromagnetically stimulating living mammalian cells

Also Published As

Publication number Publication date
GB8500007D0 (en) 1985-02-13

Similar Documents

Publication Publication Date Title
Kubasova et al. Biological effect of He‐Ne laser: Investigations on functional and micromorphological alterations of cell membranes, in vitro
Norton Effects of a pulsed electromagnetic field on a mixed chondroblastic tissue culture.
Sisken et al. Stimulation of rat sciatic nerve regeneration with pulsed electromagnetic fields
Tzagoloff Assembly of the Mitochondrial Membrane System: IV. ROLE OF MITOCHONDRIAL AND CYTOPLASMIC PROTEIN SYNTHESIS IN THE BIOSYNTHESIS OF THE RUTAMYCIN-SENSITIVE ADENOSINE TRIPHOSPHATASE
Chu et al. Immunoelectron microscopic identification of Langerhans cells using a new antigenic marker
Dennert et al. Effects of cytotoxic monoclonal antibody specific for T200 glycoprotein on functional lymphoid cell populations
Postow et al. Modulated fields and" window" effects,"
DE69433933D1 (en) METHOD AND DEVICE FOR ENCODING BIOLOGICALLY ACTIVE SUBSTANCES IN CELLS
Rusovan et al. Stimulation of regeneration of the rat sciatic nerve by 50 Hz sinusoidal magnetic fields
ATE347595T1 (en) HUMAN GROWTH FACTOR 2, SPECIFIC TO VASCULAR ENDOTHELIAL CELLS
Wasserman et al. Use of a colorimetric microtiter (MTT) assay in determining the radiosensitivity of cells from murine solid tumors
Blinowska et al. Cell membrane as a possible site of Fröhlich's coherent oscillations
WO1999043788A1 (en) In vitro model for viral infection and immune response
GB2169312A (en) A method for producing proteins
Kitani et al. Correlation between the biliary excretion of ouabain and the lateral mobility of hepatocyte plasma membrane proteins in the rat—the effects of age and spironolactone pretreatment
Cossarizza et al. Exposure to low-frequency pulsed electromagnetic fields increases mitogen-induced lymphocyte proliferation in Down’s syndrome
Hall et al. The oxidation of serum sulph-hydryl groups by hydrogen peroxide secreted by stimulated phagocytic cells in rheumatoid arthritis
Csato et al. Enhancement of Candida albicans killing activity of separated human epidermal cells by ultraviolet radiation
Pafková et al. Developmental effects of magnetic field (50 Hz) in combination with ionizing radiation and chemical teratogens
Kazin et al. The effect of a constant magnetic field on components of protein structures in human blood
Cripps et al. Effect of monochromatic UV radiation on DNA synthesis with in vivo and in vitro autoradiography
AU693800B2 (en) Diagnostic agents for osteoporosis
Pérez et al. Ovine squamous cell carcinoma: immunocharacterisation of neoplastic cells and peritumoural cellular infiltrate
Lederer et al. Influence of light on human immunocompetent cells in vitro
Jordan et al. In vitro properties and organ uptake of rat band 3 cross-linked erythrocytes

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)